These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8314173)

  • 21. Clinical significance of haemostatic tests in chronic liver disease.
    Saray A; Mesihovic R; Vanis N; Gornjakovic S; Prohic D
    Med Arch; 2012; 66(4):231-5. PubMed ID: 22919876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?
    Al Ghumlas AK; Abdel Gader AG; Al Faleh FZ
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):329-35. PubMed ID: 15970716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper concentrations are prevalently associated with antithrombin III, but also with prothrombin time and fibrinogen in patients with liver cirrhosis: A cross-sectional retrospective study.
    Tarantino G; Citro V; Capone D; Gaudiano G; Sinatti G; Santini SJ; Balsano C
    J Trace Elem Med Biol; 2021 Dec; 68():126802. PubMed ID: 34091123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased protein S activity in sickle cell disease.
    Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver disease.
    Páramo JA; Sangro B; Prósper F; Quiroga J; Rifón J; Rocha E
    Haemostasis; 1995; 25(6):305-11. PubMed ID: 8586322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional study.
    Lentschener C; Flaujac C; Ibrahim F; Gouin-Thibault I; Bazin M; Sogni P; Samama CM
    Eur J Anaesthesiol; 2016 Feb; 33(2):126-33. PubMed ID: 26258657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turnover study of prothrombin, antithrombin III and fibrinogen in patients with liver cirrhosis.
    Saitoh H; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1263-74. PubMed ID: 3811789
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis.
    Bos S; van den Boom B; Kamphuisen PW; Adelmeijer J; Blokzijl H; Schreuder T; Lisman T
    Thromb Haemost; 2019 Feb; 119(2):246-253. PubMed ID: 30609442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
    Nalçaci M; Pekçelen Y
    J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hemodialysis on protein C, protein S, and antithrombin III levels.
    Lai KN; Yin JA; Yuen PM; Li PK
    Am J Kidney Dis; 1991 Jan; 17(1):38-42. PubMed ID: 1824735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?).
    Yalçinkaya F; Tümer N; Gorgani AN; Ekim M; Cakar N
    Int Urol Nephrol; 1995; 27(5):643-7. PubMed ID: 8775051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The coagulopathy of liver disease: does vitamin K help?
    Saja MF; Abdo AA; Sanai FM; Shaikh SA; Gader AG
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):10-7. PubMed ID: 23080365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.
    Pectasides D; Tsavdaridis D; Aggouridaki C; Tsavdaridou V; Visvikis A; Tsatalas K; Fountzilas G
    Anticancer Res; 1999; 19(4C):3521-6. PubMed ID: 10629646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clotting profile in cattle showing chronic enzootic haematuria (CEH) and bladder neoplasms.
    Di Loria A; Piantedosi D; Cortese L; Roperto S; Urraro C; Paciello O; Guccione J; Britti D; Ciaramella P
    Res Vet Sci; 2012 Aug; 93(1):331-5. PubMed ID: 21839485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Haemostatic defects in venous thromboembolic disease].
    Grzywacz A; Psuja P; Turowiecka Z; Lewandowski K; Zozulińska M; Zawilska K
    Pol Arch Med Wewn; 1995 Oct; 94(4):307-13. PubMed ID: 8834124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of anticoagulant proteins in chronic liver diseases.
    Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
    Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of splenectomy on blood coagulation and fibrinolysis in patients with liver cirrhosis: possible role of the spleen in haemostasis.
    Kamisasa I; Hidai K; Sugiura M; Wada T; Yamanaka M
    Thromb Haemost; 1980 Feb; 42(5):1529-35. PubMed ID: 6989011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in coagulation inhibitors (AT III, protein C, protein S) in patients with liver cirrhosis].
    Kobayashi I; Kurihara A; Hamaoka S; Amemiya N; Endo T; Okuyama K
    Rinsho Byori; 1989 Apr; Spec No 81():93-7. PubMed ID: 2526888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.